Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

SCLC, Extensive Stage × atezolizumab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Hepatocellular 51 Carcinoma, Non-Small-Cell Lung 49 Lung Neoplasms 27 Neoplasms 23 Small Cell Lung Carcinoma 21 Breast Neoplasms 20 Colorectal Neoplasms 18 Neoplasm Metastasis 15 Melanoma 15 Carcinoma, Transitional Cell 14 Urinary Bladder Neoplasms 13 Triple Negative Breast Neoplasms 12 Carcinoma, Renal Cell 10 Squamous Cell Carcinoma of Head and Neck 9 Stomach Neoplasms 8 Prostatic Neoplasms 7 Ovarian Neoplasms 7 Glioblastoma 7 Endometrial Neoplasms 7 Uterine Cervical Neoplasms 6 Head and Neck Neoplasms 6 Pancreatic Neoplasms 5 Liver Neoplasms 5 Sarcoma 4 Rectal Neoplasms 4 Kidney Neoplasms 4 Esophageal Neoplasms 4 Colonic Neoplasms 4 Carcinoma, Neuroendocrine 4 Carcinoma, Merkel Cell 4

Interventions

toripalimab 1 fluzoparib 1 atezolizumab 1 Topotecan 1 Temozolomide 1 PM 01183 1 Etoposide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04221529 2025-09-08

SPACE

AIO-Studien-gGmbH

Phase 2 Completed

SCLC, Extensive Stage

Data powered by HemOnc (CC BY 4.0) Colophon ⚡